Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

L.A. McKeown

June 09, 2023

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

L.A. McKeown

April 22, 2021

News Conference News LINC 2020

Algorithm Aims to Help Operators Pair Laser Settings With PAD Lesion Type

L.A. McKeown

February 06, 2020

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Daily News

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

L.A. McKeown

October 26, 2015

News Daily News

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

L.A. McKeown

October 26, 2015

News Daily News

DCB治疗膝下病变又传出令人失望的消息

L.A. McKeown

October 26, 2015

Presentation

Paclitaxel-Coated Balloon in Infrapopliteal Arteries

Presenter: Thomas Zeller

October 23, 2015

News Industry News

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

October 06, 2015

News Industry News

QT Vascular wins CE Mark for drug-coated balloon

September 10, 2015

News Industry News

First Subject Enrolled in Veryan Medical's MIMICS-2 Study

July 01, 2015

Presentation ISET 2015

Drug-Coated Balloons: How Does It Change the Treatment Landscape for CLI?

Presenter: Thomas Zeller

February 03, 2015

Presentation ISET 2015

Benefits of DCB in SFA Disease

Presenter: Thomas Zeller

February 01, 2015

Presentation TCT 2013

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Presenter: Thomas Zeller

October 31, 2013

Presentation TCT 2012

Role of DCB in SFA Intervention: Predictions Five Years into the Future

Presenter: Thomas Zeller

October 25, 2012

Advertisement

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

Algorithm Aims to Help Operators Pair Laser Settings With PAD Lesion Type

SELUTION™ First-in-Man Study Achieves Primary Endpoint

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

DCB治疗膝下病变又传出令人失望的消息

Paclitaxel-Coated Balloon in Infrapopliteal Arteries

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

QT Vascular wins CE Mark for drug-coated balloon

First Subject Enrolled in Veryan Medical's MIMICS-2 Study

Drug-Coated Balloons: How Does It Change the Treatment Landscape for CLI?

Benefits of DCB in SFA Disease

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Role of DCB in SFA Intervention: Predictions Five Years into the Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content